Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03189498
What this trial is testing

Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal Function

Who this might be right for
Renal Insufficiency
Janssen Pharmaceutica N.V., Belgium 38
Early research (Phase 1)Study completedNCT01674192
What this trial is testing

Prucalopride Subjects With Renal Impairment

Who this might be right for
Constipation
Movetis 34
Early research (Phase 1)Study completedNCT03318809
What this trial is testing

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function

Who this might be right for
Heart Failure
Amgen 12
Early research (Phase 1)Study completedNCT01478399
What this trial is testing

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

Who this might be right for
Diabetes Mellitus, Type 2
PhaseBio Pharmaceuticals Inc. 16
Large-scale testing (Phase 3)Study completedNCT03418168
What this trial is testing

Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 51
Early research (Phase 1)Ended earlyNCT02808052
What this trial is testing

Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency

Who this might be right for
Renal Insufficiency, AcuteRenal Insufficiency, ChronicHealthy Subjects
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 9
Early research (Phase 1)Study completedNCT01309438
What this trial is testing

Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function

Who this might be right for
HealthyRenal Insufficiency
Janssen Research & Development, LLC 29
Early research (Phase 1)Study completedNCT04056455
What this trial is testing

Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys

Who this might be right for
Renal ImpairmentHealthy Volunteers
Millennium Pharmaceuticals, Inc. 26
Early research (Phase 1)Study completedNCT05368935
What this trial is testing

Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects

Who this might be right for
Renal ImpairmentRenal DiseaseKidney Disease
Genfit 77
Early research (Phase 1)Study completedNCT03546205
What this trial is testing

Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function

Who this might be right for
Kidney Failure, Chronic
Janssen Research & Development, LLC 40
Large-scale testing (Phase 3)Ended earlyNCT05356403
What this trial is testing

CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Who this might be right for
Chronic Kidney DiseasesPruritus
Cara Therapeutics, Inc. 105
Post-approval studies (Phase 4)Study completedNCT03236246
What this trial is testing

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

Who this might be right for
Chronic Kidney DiseasesIron Deficiency Anemia
Keryx Biopharmaceuticals 206
Early research (Phase 1)Study completedNCT04899219
What this trial is testing

Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects

Who this might be right for
Healthy
Idorsia Pharmaceuticals Ltd. 16
Post-approval studies (Phase 4)Study completedNCT00111995
What this trial is testing

Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis

Who this might be right for
Chronic Renal FailureAnemia
Amgen 400
Not applicableEnded earlyNCT00568009
What this trial is testing

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Who this might be right for
Congestive Heart Failure
Solvay Pharmaceuticals 300
Large-scale testing (Phase 3)Study completedNCT02540993
What this trial is testing

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Bayer 5,734
Early research (Phase 1)Study completedNCT01578928
What this trial is testing

A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 50
Early research (Phase 1)Study completedNCT01459250
What this trial is testing

Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT02696642
What this trial is testing

Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment

Who this might be right for
Neoplasms
Bayer 54
Early research (Phase 1)Study completedNCT02254070
What this trial is testing

Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment

Who this might be right for
Healthy
Boehringer Ingelheim 23
Next Page